[{"Assets_0_Q1_USD":489707000.0,"EarningsPerShareBasic_1_Q1_USD":0.16,"EarningsPerShareDiluted_1_Q1_USD":0.15,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":10708000.0,"NetIncomeLoss_1_Q1_USD":5491000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":102701000.0,"StockholdersEquity_0_Q1_USD":414921000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":35917051.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":33846142.0,"Ticker":"PEN","CIK":"1321732","name":"PENUMBRA INC","OfficialName":"Penumbra Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7821675869.0","Country":"nan","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NYSE","SP500":"nan","filed":"20180508"}]